Investor · New York, NY

Joel J. Marcus

Open Joel in the network graph →

Filings

24

SEC Form D

Connections

126

co-filers

Capital

$62.4M

across filings

Active

Dec 2013

to Jul 2024

Most-connected co-filers (126)

David J. Schubert · New York, NY24 shared David J. Mcelligott · New York, NY14 shared Thong Le · New York, NY14 shared Lindsay J. Rayle · New York, NY14 shared Barbara J. Dalton · New York, NY12 shared M. J. Erwin · New York, NY12 shared Christopher Y. Thorne · New York, NY10 shared Paul Watson · Houston, TX10 shared Steve T. Gillis · Cambridge, MA8 shared Ibis Investments, LLC · New York, NY7 shared Ibis Management, LLC · New York, NY7 shared Stephen A. Herrod · Palo Alto, CA6 shared Asish Xavier · San Francisco, CA6 shared James Sullivan · Berkshire, United Kingdom6 shared Misti R. Ushio · Gaithersburg, MD6 shared Steve Gillis · New York, NY5 shared Ajit Sancheti · San Francisco, CA5 shared Gordon L. Roth · Newport Beach, CA5 shared Michael T. Yang · Plymouth Meeting, PA4 shared J. M. Cline · Plymouth Meeting, PA4 shared William T. Frist, Sr · Plymouth Meeting, PA4 shared Mark T. Mactas · Plymouth Meeting, PA4 shared Byron L. Roth · Newport Beach, CA4 shared Thomas J. Neff · Plymouth Meeting, PA4 shared

Recent filings (24)

IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2024 · 5 co-filers IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2023 · 5 co-filers IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2022 · 5 co-filers IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2021 · 5 co-filers IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2020 · 5 co-filers IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2019 · 3 co-filers IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2018 · 3 co-filers Accolade, Inc.Mar 2018 · 44 co-filers$50.0M Petra Pharma CorpJan 2018 · 34 co-filers$48.3M IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2017 · 3 co-filers Lodo Therapeutics CorpJan 2017 · 31 co-filers$19.9M Petra Pharma CorpJan 2017 · 25 co-filers$48.3M Accolade, Inc.Aug 2016 · 31 co-filers$60.0M IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2016 · 5 co-filers Petra Pharma CorpJan 2016 · 28 co-filers$10.4M Lodo Therapeutics CorpJan 2016 · 29 co-filers$3.7M Accolade, Inc.Dec 2015 · 31 co-filers$53.6M IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2015 · 5 co-filers Accolade, Inc.Jul 2015 · 30 co-filers$35.0M Boyd Watterson Ltd Duration Mid-Grade Fund, LLCJul 2015 · 20 co-filers Boyd Watterson Ltd Duration Mid-Grade Fund, LLCSep 2014 · 12 co-filers Accolade, Inc.May 2014 · 20 co-filers$2.8M Accolade, Inc.Dec 2013 · 20 co-filers$30.0M Boyd Watterson Ltd Duration Mid-Grade Fund, LLCJul 2013 · 12 co-filers

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Joel in the interactive graph →